期刊文献+

耐药结核病化学治疗研究的过去、现状与未来 被引量:12

The past, present and future of study in the chemotherapy of drug-resistant tuberculosis
暂未订购
导出
摘要 耐药结核病的流行是当前结核病控制工作面临的主要挑战之一,严重威胁人们在结核病控制领域所取得的成就.抗结核药物是控制结核病的最有效武器,但面对耐多药结核病尤其是广泛耐药结核病明显力不从心,结核病有可能因此而再度成为“不治之症”.研制更有效的抗结核药物,设计具有抗耐药结核病的化学治疗方案,化解耐药结核病的治疗困境,迫在眉睫.作者通过回顾历史,着眼现在,展望未来,阐述耐药结核病化学治疗的若干问题,期待有助于读者对耐药结核病化学治疗研究有一个较为全面的认识,共同探索化学治疗控制耐药结核病流行的可行性. The prevalence of drug resistant tuberculosis (TB) is one of the main challenges on current TB control which seriously influences the achievement people had made in this field.Anti-TB drugs are the most effective weapons in controlling TB,however,they have been obviously not enough to deal with multidrug-resistant TB,especially extensively drug resistant TB,TB is more likely to become the incurable disease again because of this reason.Therefore,it is urgent to develop more effective anti-TB drugs,design the chemotherapy regiment on drug-resistant TB and solve the difficulty in treating drug-resistant TB.The authors reviewed the history,focused on the present and looked ahead the future,elucidated several issues about treatment on drug-resistant TB and had expectation that readers would have a comprehensively understanding of chemotherapy for drug resistant TB and make efforts altogether to explore the possibility of controlling the epidemic of drug-resistant TB by chemotherapy.
出处 《中国防痨杂志》 CAS 2014年第8期634-637,共4页 Chinese Journal of Antituberculosis
关键词 结核 抗多种药物性 药物疗法 临床方案 回顾性研究 Tuberculosis, multidrug-resistant/drug therapy Clinical protocols Retrospective studies
  • 相关文献

参考文献22

  • 1Grosset J. The sterilizing value of rifarnpicin and pyrazinamide in experimental short course chemotherapy. Bull Int Union Tu bert, 1978,53(1):5-12.
  • 2[No authors listed]. Controlled elinieal trial of four shorv course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils. Lancet, 1974, 2(7875) :237-240.
  • 3World Health Organization. Guidelines for the management of drug-resistant tuberculosis. WHO/TB/96. 210. Geneva: World Health Organization, 1996.
  • 4World Health Organization. Glohal tuberculosis report 2013. Geneva: World Health Organization, 2013.
  • 5Sbarbaro JA, Iseman MD, Crowle AJ. Combined effect of pyraziamide and ofloxaein within the human maerophage. Tu ber LunR Dis, 1996, 72(6):491-495.
  • 6耐多药结核病化学治疗的意见(试行)[J].中国防痨杂志,2003,25(1):4-9. 被引量:145
  • 7肖和平.耐药结核病化学治疗指南(2009)[J].中国防痨杂志,2010,32(4):181-198. 被引量:142
  • 8World Health Organization. Guidelines for the programmatic- management of drug-resistant tuberculosis. 2011 update. WHO/HTM/TB/2011.6. Geneva: World Health Organiza- tion, 2011.
  • 9Sullivan EA, Kreiswirth BN, Palumbo L, et al. Emergence of fluoroquinolone-resistant tuberculosis in New York City. Lan- cet, 1995,345(8958) : 1148-1150.
  • 10肖和平.耐多药结核病化疗药物的选择与方案的制定[J].中华结核和呼吸杂志,2006,29(8):517-519. 被引量:32

二级参考文献67

共引文献431

同被引文献368

引证文献12

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部